Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Courtney Johnson, Jennifer Stephens, Christopher Walker, Joseph C Cappelleri & Ahmed Shelbaya. (2020) Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis. ClinicoEconomics and Outcomes Research 12, pages 57-67.
Read now
Read now
Articles from other publishers (3)
Shingo Higa, Ken Nakata, Yusuke Karasawa & Kazuhiro Ohwaki. (2023) Comparative effectiveness of early initiation of oral nonsteroidal anti-inflammatory drug and oral acetaminophen therapies on the time to knee replacement in patients with knee osteoarthritis in Japan. BMC Musculoskeletal Disorders 24:1.
Crossref
Crossref
Kayla M. Scott, D. Joshua Cohen, Barbara D. Boyan & Zvi Schwartz. (2022) miR‐122 and the WNT/β‐catenin pathway inhibit effects of both interleukin‐1β and tumor necrosis factor‐α in articular chondrocytes in vitro. Journal of Cellular Biochemistry 123:6, pages 1053-1063.
Crossref
Crossref
Bethan Copsey, James Buchanan, Raymond Fitzpatrick, Sarah E. Lamb, Susan J. Dutton & Jonathan A. Cook. (2019) Duration of Treatment Effect Should Be Considered in the Design and Interpretation of Clinical Trials: Results of a Discrete Choice Experiment. Medical Decision Making 39:4, pages 461-473.
Crossref
Crossref